Next-Generation Approaches To Statistical Significance

Christian K Schneider | Head of Biopharma Excellence / Chief Medical Officer

The panel considered the potential for supplementary data sets – such as pharmacodynamic read-outs, histological evidence and historical controls – in enabling regulators to reach robust decisions.

Start a conversation today

Socials: